LETTER
Cycloisomerization of 1-Allenyl-1-ethynyl Acetate
1083
H, m), 2.27 (1 H, br s), 2.55 (1 H, s), 5.01 (2 H, d, J = 6.4 Hz), 5.11
(1 H, t, J = 6.8 Hz), 5.38 (1 H, t, J = 6.4 Hz). 13C NMR (100 MHz,
CDCl3): d (major diastereomer) = 17.7, 21.1, 25.4, 25.7, 29.2, 38.2,
49.0, 68.9, 73.0, 79.8, 85.8, 98.3, 124.8, 131.2, 205.9. IR (neat):
3419, 3306, 1957, 847 cm–1. HRMS (EI): m/z [M+] calcd for
C15H22O: 218.1671; found: 218.1669.
A plausible mechanism of the present reaction is proposed
as shown in Scheme 6.3b 5-exo-dig Cyclization of 1-alle-
nyl-1-ethynyl acetates 1 via nucleophilic attack of the
alkyne by a carbonyl oxygen in accordance with Mark-
ovnikov’s rule generates vinyl gold species B. Cyclization
of vinyl gold species B produces cationic intermediate C,
which upon elimination of cationic gold(III), affords ful-
vene derivative A. Methanolysis of A gives the product 2.
General Procedure for the Preparation of Substrates 1
To a solution of 4 (5 mmol) in pyridine (2 mL) and Ac2O (1.5 mL)
was added 4-dimethylaminopyridine (20 mg) and the mixture was
stirred for 1.5–3 h at r.t. The mixture was diluted with H2O (50 mL)
and EtOAc (50 mL). The layers were separated, the aqueous layer
was extracted with EtOAc (50 mL), and the combined organic lay-
ers were washed with 10% HCl aq, sat. NaHCO3 aq, and H2O. The
organic layers were dried with MgSO4 and concentrated in vacuo.
The product was pure enough to use for further reaction.
Compound 1a: colorless oil. 1H NMR (400 MHz, CDCl3): d = 2.04
(3 H, s), 2.16–2.23 (1 H, m), 2.31–2.38 (1 H, m), 2.70 (1 H, s), 2.82–
2.90 (2 H, m), 5.00–5.06 (2 H, m), 5.68 (1 H, t, J = 6.8 Hz), 7.17–
7.31 (5 H, m). 13C NMR (100 MHz, CDCl3): d = 21.7, 30.6, 42.1,
74.6, 74.9, 79.6, 81.6, 94.1, 126.0, 128.4 (2 C), 128.5 (2 C), 141.3,
169.0, 207.5. IR (neat): 1954, 1747, 1231 cm–1. HRMS (EI): m/z
[M+] calcd for C16H16O2: 240.1150; found: 240.1147.
Compound 1b: colorless oil. 1H NMR (400 MHz, CDCl3): d = 2.02
(3 H, s), 2.64 (1 H, s), 3.21 (1 H, d, J = 13.6 Hz), 3.33 (1 H, d,
J = 13.6 Hz), 4.92–5.02 (2 H, m), 5.57 (1 H, t, J = 6.8 Hz), 7.25–
7.31 (5 H, m). 13C NMR (100 MHz, CDCl3): d = 21.7, 46.4, 74.8,
75.8, 79.6, 81.4, 94.1, 127.1, 127.8 (2 C), 131.1 (2 C), 135.0, 168.9,
207.4. IR (neat): 3284, 2120, 1957, 1743, 1216 cm–1. HRMS (EI):
m/z [M+] C15H14O2: 226.0994; found: 226.0992.
Compound 1c: colorless oil. 1H NMR (400 MHz, CDCl3): d = 0.88
(3 H, t, J = 6.8 Hz), 1.25–1.32 (12 H, m), 1.46–1.55 (2 H, m), 1.85–
1.93 (1 H, m), 1.97–2.03 (1 H, m), 2.04 (3 H, s), 2.62 (1 H, s), 4.94–
5.03 (2 H, m), 5.60 (1 H, t, J = 6.6 Hz). 13C NMR (100 MHz,
CDCl3): d = 14.1, 21.7, 22.7, 24.1, 29.3, 29.4, 29.5, 29.6, 31.9, 40.4,
74.4, 75.1, 79.3, 81.9, 94.3, 169.0, 207.5. IR (neat): 2925, 2120,
1957, 1746, 1226 cm–1. HRMS (EI): m/z [M+] C17H26O2: 262.1933;
found: 262.1933.
In conclusion, we have reported the cycloisomerization of
1-allenyl-1-ethynyl acetates 1 using new cationic box–
Au(III) complexes, [(S,S)-PhboxAuCl2]SbF6 or [(R,R)-
Bnbox AuCl2]SbF6 afforded 4-methylene-2-cyclopenten-
ones 2 in 60–69% yield. An application of the complexes
to an asymmetric reaction is now in progress.
General Procedure for the Preparation of 4
To a solution of trimethylsilyl acetylene (3.81g, 38.8 mmol) in THF
(30 mL) under Ar was added n-BuLi (12.8 mL of 2.6 M in hexane,
33.3 mmol) at –78 °C and the mixture was stirred for 0.5 h at 0 °C.
After the solution was cooled to –78 °C, the corresponding alle-
nylketone 3 (11.1 mmol) in THF (3 × 8 mL) was added slowly drop-
wise. The mixture was stirred at –15 °C for 12 h and quenched with
H2O (80 mL) and EtOAc (80 mL). The layers were separated, the
aqueous layer was extracted with EtOAc (50 mL), and combined or-
ganic layers were dried with MgSO4 and concentrated in vacuo. The
crude product was purified by column chromatography on silica
gel. The fraction eluted with hexane–EtOAc (100:1 to 50:1) afford-
ed 4.
Compound 4a: colorless oil. 1H NMR (400 MHz, CDCl3): d = 2.07–
2.12 (2 H, m), 2.39 (1 H, br s), 2.60 (1 H, s), 2.85–2.90 (2 H, m),
5.03 (2 H, d, J = 6.9 Hz), 5.43 (1 H, t, J = 6.9 Hz), 7.17–7.30 (5 H,
m). 13C NMR (100 MHz, CDCl3): d = 30.8, 44.1, 68.8, 73.2, 80.0,
85.0, 97.4, 125.9, 128.4 (2 C), 128.4 (2 C), 141.6, 206.1. IR (neat):
3390, 2114, 1956, 852 cm–1. HRMS (EI): m/z [M+] calcd for
C14H14O: 198.1045; found: 198.1039.
Compound 1d: colorless oil. 1H NMR (400 MHz, CDCl3): d = 0.89
(3 H, t, J = 6.8 Hz), 1.25–1.34 (10 H, m), 1.45–1.55 (2 H, m), 1.85–
1.93 (1 H, m), 1.97–2.03 (1 H, m), 2.04 (3 H, s), 2.62 (1 H, s), 4.94–
5.03 (2 H, m), 5.60 (1 H, t, J = 6.8 Hz). 13C NMR (100 MHz,
CDCl3): d = 14.1, 21.8, 22.7, 24.1, 29.2, 29.4, 29.5, 31.9, 40.4, 74.4,
75.1, 79.2, 82.0, 94.3, 169.0, 207.5. IR (neat): 2954, 2120, 1957,
1746, 1227 cm–1. HRMS (EI): m/z [M+] C16H24O2: 248.1776; found:
248.1775.
Compound 4b: colorless oil. 1H NMR (400 MHz, CDCl3): d = 2.30
(1 H, s), 2.56 (1 H, s), 3.06 (1 H, d, J = 13.6 Hz), 3.10 (1 H, d,
J = 13.6 Hz), 4.98 (2 H, d, J = 6.7 Hz), 5.43 (1 H, t, J = 6.7 Hz),
7.25–7.35 (5 H, m). 13C NMR (100 MHz, CDCl3): d = 48.4, 68.8,
74.0, 79.9, 84.8, 97.0, 127.1, 128.0 (2 C), 131.0 (2 C), 135.3, 206.1.
IR (neat): 3403, 1958, 699 cm–1. HRMS (EI): m/z [M+] calcd for
C13H12O: 184.0888; found: 184.0882.
Compound 4c: colorless oil. 1H NMR (400 MHz, CDCl3): d = 0.88
(3 H, t, J = 7.2 Hz), 1.24–1.33 (12 H, m), 1.46–1.56 (2 H, m), 1.75–
1.80 (2 H, m), 2.25 (1 H, br s), 2.53 (1 H, s), 5.01 (2 H, d, J = 6.4
Hz), 5.37 (1 H, t, J = 6.4 Hz). 13C NMR (100 MHz, CDCl3): d =
14.1, 22.7, 24.3, 29.3, 29.5, 29.5, 29.5, 31.9, 42.5, 69.1, 72.7, 79.7,
85.4, 97.5, 206.1. IR (neat): 3387, 3309, 2923, 2116, 1958 cm–1.
HRMS (EI): m/z [M+] calcd for C15H24O: 220.1827; found:
220.1831.
Compound 4d: colorless oil. 1H NMR (400 MHz, CDCl3): d = 0.88
(3 H, t, J = 6.8 Hz), 1.25–1.35 (10 H, m), 1.47–1.57 (2 H, m), 1.71–
1.83 (2 H, m), 2.32 (1 H, br s), 2.53 (1 H, s), 5.00 (2 H, d, J = 6.6
Hz), 5.37 (1 H, t, J = 6.6 Hz). 13C NMR (100 MHz, CDCl3): d =
14.1, 22.7, 24.3, 29.3, 29.5, 29.6, 31.9, 42.5, 69.1, 72.7, 79.7, 85.4,
97.5, 206.1. IR (neat): 3399, 3309, 1958, 1738, 988 cm–1. HRMS
(EI): m/z [M+] calcd for C14H22O: 206.1671; found: 206.1671.
1
Compound 1e: colorless oil (diastereomeric mixture, dr = 6:5). H
NMR (400 MHz, CDCl3): d = 1.01 and 1.03 (total 3 H, each as d,
J = 6.8 Hz), 1.20–1.31 (1 H, m), 1.41–1.52 (1 H, m), 1.61 (3 H, s),
1.68 (3 H, s), 1.77–1.90 (3 H, m), 1.95–2.07 (2 H, m), 2.04 (3 H, s),
2.64 (1 H, s), 4.94–5.03 (2 H, m), 5.10 (1 H, t, J = 6.8 Hz), 5.58–
5.62 (1 H, m). 13C NMR (100 MHz, CDCl3): d (major diastereo-
mer) = 17.7, 21.1, 21.8, 25.3, 25.7, 29.1, 38.0, 47.1, 74.7, 75.1, 79.4,
82.1, 94.9, 124.7, 131.2, 168.9, 207.3. IR (neat): 2918, 1957, 1746,
1225 cm–1. HRMS (EI): m/z [M+] C17H24O2: 260.1776; found:
260.1770.
General procedure for the cycloisomerization reaction of 1
To a solution of 1 (50 mg) in toluene (5 mL) was added the catalyst
(5 mol%) and the mixture was stirred at r.t. The mixture was moni-
tored by TLC until all the substrate had been consumed (1 → A),
then K2CO3 (86 mg, 0.62 mmol) and MeOH (3 mL) were added.
After stirring for 30 min, the mixture was diluted with EtOAc (20
mL), and washed with 3% NaHCO3 aq (20 mL). The layers were
separated, the aqueous layer was extracted with EtOAc (20 mL),
1
Compound 4e: colorless oil (diastereomeric mixture, dr = 6:5). H
NMR (400 MHz, CDCl3): d = 1.02 and 1.04 (total 3 H, each as d,
J = 6.5 Hz), 1.18–1.28 (1 H, m), 1.39–1.53 (1 H, m), 1.60 (3 H, s),
1.63–1.66 (1 H, m), 1.68 (3 H, s), 1.78–1.86 (2 H, m), 1.91–2.03 (2
Synlett 2008, No. 7, 1081–1085 © Thieme Stuttgart · New York